BENGALURU - Serum Institute of India said on Wednesday that trials of AstraZeneca Plc’s COVID-19 vaccine candidate in the country is ongoing and has not faced any issues.
AstraZeneca said it has paused global trials, including large late-stage trials, of its experimental coronavirus vaccine due to an unexplained illness in a study participant.
“We can’t comment much on the U.K. trials,” Serum Institute said in a statement, adding “as far as Indian trials are concerned, it is continuing and we have faced no issues at all.”